Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 301–400 of 1,000
Decreased phagocytosis of apoptotic cells in diseased SLE mice
Licht, R., Dieker, J. W. C., Jacobs, C. W. M., Tax, W. J. M., & Berden, J. H. M. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2003.11.003 · Cited by 135
Gene-function studies in systemic lupus erythematosus
Crispín, J. C., Hedrich, C. M., & Tsokos, G. C. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.78 · Cited by 130
Developmental activities of the complement pathway in migrating neurons
Gorelik, A., Sapir, T., Haffner‐Krausz, R., Olender, T., Woodruff, T. M., & Reiner, O. (2017) · Nature Communications · doi:10.1038/ncomms15096 · Cited by 130
Vukojicic, A., Delestrée, N., Fletcher, E. V., Pagiazitis, J. G., Sankaranarayanan, S., Yednock, T. A., Barres, B. A., & Mentis, G. Z. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.013 · Cited by 120
“C1qadeficient mice (C57BL/6) have no C1q protein and have disrupted classical complement activity (Botto et al., 1998).”
BackgroundMethodInfluentialA role of macrophage complement receptor CRIg in immune clearance and inflammation
He, J. Q., Wiesmann, C., & Campagne, M. V. L. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.011 · Cited by 138
Human C1qRp Is Identical with CD93 and the mNI-11 Antigen But Does Not Bind C1q
McGreal, E. P., Ikewaki, N., Akatsu, H., Morgan, B. P., & Gasque, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5222 · Cited by 120
“C1q-deficient mice also develop an SLE-like disease that is similar in many respects to that observed in humans and that is characterized by a deficiency in apoptotic cell clearance and pronounced glomerulonephritis (8).”
ResultPetry, F., Botto, M., Holtappels, R., Walport, M. J., & Loos, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4033 · Cited by 95
“C1qa / mice used were on a hybrid genetic background (129/Sv C57BL/6) or backcrossed onto C57BL/6 for seven generations, as specified in each experiment, and were generated as previously described (5).”
BackgroundMethodSelf-citationMechanisms of Tissue Injury in Lupus Nephritis
Flores-Mendoza, G., Sansón, S. P., Rodríguez-Castro, S., Crispín, J. C., & Rosetti, F. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.003 · Cited by 126
Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens
Lech, M., Kulkarni, O. P., Pfeiffer, S., Savarese, E., Krug, A., Garlanda, C., Mantovani, A., & Anders, H.-J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072646 · Cited by 115
Monomeric C‐reactive protein modulates classic complement activation on necrotic cells
Mihlan, M., Blom, A. M., Kupreishvili, K., Lauer, N., Stelzner, K., Bergström, F., Niessen, H. W. M., & Zipfel, P. F. (2011) · The FASEB Journal · doi:10.1096/fj.11-186460 · Cited by 121
Nucleic acids and endosomal pattern recognition: how to tell friend from foe?
Brencicova, E., & Diebold, S. S. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00037 · Cited by 114
“…regulatory role of C1q in preventing innate immune activation by dead cells accumulating in the tissue is underpinned by the finding that C1q deficiency leads to autoimmunity induction in humans and mice resulting in SLE and SLE-like symptoms, respectively (Schur, 1977; Botto et al., 1998).”
BackgroundWilkinson, R., Lyons, A. B., Roberts, D., Wong, M.-X., Bartley, P. A., & Jackson, D. E. (2002) · Blood · doi:10.1182/blood-2002-01-0027 · Cited by 129
Ryan, B. J., Nissim, A., & Winyard, P. G. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.004 · Cited by 119
NETs: the missing link between cell death and systemic autoimmune diseases?
Darrah, E., & Andrade, F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00428 · Cited by 133
“…Napirei et al., 2000; Cohen et al., 2002; Hanayama et al., 2004), disease expression is frequently dependent on background genes (e.g., C1q-, C4-, SAP-deficient mice; Botto et al., 1998; Bickerstaff et al., 1999; Chen et al., 2000; Mitchell et al., 2002; Paul et al., 2002; Gillmore et al., 2004).”
BackgroundModular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains
Kishore, U., Gupta, S. K., Perdikoulis, M. V., Kojouharova, M. S., Urban, B. C., & Reid, K. B. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.812 · Cited by 119
Leverrier, Y., Lorenzi, R., Blundell, M. P., Brickell, P., Kinnon, C., Ridley, A. J., & Thrasher, A. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4831 · Cited by 119
“Therefore, it has been suggested that impaired clearance of apoptotic cells (which are a major source of autoantigen) is responsible for the development of systemic lupus erythematosus (17, 26, 27).”
BackgroundSexual dimorphism in immune response genes as a function of puberty
Lamason, R., Zhao, P., Rawat, R., Davis, A., Hall, J. C., Chae, J. J., Agarwal, R., Cohen, P., Rosen, A., Hoffman, E. P., et al. (2006) · BMC Immunology · doi:10.1186/1471-2172-7-2 · Cited by 117
“This hypothesis is in fact supported by the finding that genetic defects in innate immune response genes (complement C1q and serum amyloid P) in mice result in spontaneous autoimmune disease [26-28].”
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
O’Brien, B. A., Geng, X., Orteu, C. H., Huang, Y., Ghoreishi, M., Zhang, Y., Bush, J., Li, G., Finegood, D. T., & Dutz, J. P. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.11.006 · Cited by 118
Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells
Familian, A., Zwart, B., Huisman, H. G., Rensink, I., Roem, D., Hordijk, P. L., Aarden, L. A., & Hack, C. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.647 · Cited by 118
“Recent studies in mice made deficient for SAP or C1q by targeted gene disruption (23, 44) support this idea: these mice have a high risk for developing systemic lupus erythematosus, a disease which likely results from impaired clearance of apoptotic cells and subsequent exposure of the immune system to nucleosomes (45…”
BackgroundComplement in the immunopathogenesis of rheumatic disease
Sturfelt, G. K., & Truedsson, L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.75 · Cited by 116
Yuste, J., Sen, A. D., Truedsson, L., Jonsson, G. G., Tay, L. S., Hyams, C. J., Baxendale, H., Goldblatt, F., Botto, M., & Brown, J. (2008) · Infection and Immunity · doi:10.1128/iai.00291-08 · Cited by 135
“were obtained by terminal exsanguinations from mice (C1q-deficient sera from C1qa / mice, Bf-deficient sera from Bf / mice, C3-deficient sera from C3 / mice, and natural-IgM-deficient sera from s / mice) (2, 15, 34, 45) that had”
Self-citationPathophysiology of Cutaneous Lupus Erythematosus
Lin, J. H., Dutz, J. P., Sontheimer, R. D., & Werth, V. P. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-0031-x · Cited by 121
Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus
Yang, F., He, Y., Zhai, Z., & Sun, E. (2019) · Journal of Immunology Research · doi:10.1155/2019/3638562 · Cited by 120
“Accumulation of renal apoptotic cells, higher titers of autoantibodies, and glomerulonephritis were observed in C1q-deficient mice [42].”
BackgroundBao, L., Osawe, I., Haas, M., & Quigg, R. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1947 · Cited by 115
“The complement system has relevance to apoptosis, both in the clearance of apoptotic cells (8, 53) and in its potential to lead to apoptosis, such as via direct effects of C5a (54) or C5b-9 (55–57) or by recruiting inflammatory cells that can themselves induce apoptosis (58, 59).”
BackgroundThe C1q Family of Proteins: Insights into the Emerging Non-Traditional Functions
Ghebrehiwet, B., Hosszu, K. K., Valentino, A., & Peerschke, E. I. B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00052 · Cited by 106
C1q and phagocytosis: the perfect complement to a good meal
Galvan, M. D., Greenlee-Wacker, M. C., & Bohlson, S. S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212099 · Cited by 106
Kravitz, M. S., Pitashny, M., & Shoenfeld, Y. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-7828-2 · Cited by 124
“Similarly, deficiencies in the early complement components, predispose humans and mice to lupus-like diseases (44–46), and an increased number of apoptotic cells are observed in the kidneys of C1qdeficient mice (46), implying that deficiency in different components of the innate immunity such as complement, or acute p…”
BackgroundApoptosis in Diseases of the Liver
Neuman, M. G. (2001) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/20014091084182 · Cited by 120
APOPTOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Andrade, F., Casciola-Rosen, L. A., & Rosen, A. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70136-8 · Cited by 113
Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers
Akhter, E., Burlingame, R. W., Seaman, A., Magder, L. S., & Petri, M. (2011) · Lupus · doi:10.1177/0961203311411597 · Cited by 112
Wu, X., Molinaro, C., Johnson, N., & Casiano, C. A. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2642::aid-art444>3.0.co;2-8 · Cited by 113
The innate immune system and the clearance of apoptotic cells
Devitt, A., & Marshall, L. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0211095 · Cited by 103
“An in vivo deficiency of C1q results in defective AC clearance and severe pathology and autoimmune consequences [51, 57].”
BackgroundSelf, Non-Self, and Danger: A Complementary View
Köhl, J. (2007) · Springer eBooks · doi:10.1007/0-387-34134-x_6 · Cited by 134
Simoni, M. G. D., Rossi, E., Storini, C., Pizzimenti, S., Echart, C., & Bergamaschini, L. C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63744-3 · Cited by 117
“C1qa / , classical pathway deficiency).(27,30) These mice have no overt phenotype with no evidence of autoimmunity.”
BackgroundCooperation between C1q and DNase I in the clearance of necrotic cell–derived chromatin
Gaipl, U. S., Beyer, T. D., Heyder, P., Kuenkele, S., Böttcher, A., Voll, R. E., Kalden, J. R., & Herrmann, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20034 · Cited by 110
Turnberg, D., Lewis, M., Moss, J., Xu, Y., Botto, M., & Cook, H. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4094 · Cited by 110
Self-citationVratsanos, G., Jung, S. S., Park, Y., & Craft, J. E. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.329 · Cited by 110
“Identification of a lower threshold for activation in lupus T cells does not preclude other intrinsic abnormalities in the immune system from contributing to a predisposition to autoimmunity, such as abnormalities in B cell (26, 33, 34) or APC function (35), or in clearance of immune complexes (36).”
BackgroundMannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo
McMullen, M. E., Hart, M. L., Walsh, M. C., Buras, J. A., Takahashi, K., & Stahl, G. L. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.06.011 · Cited by 110
“…CD59 IgM antibody (clone C2G4; gift from Dr. Lloyd Klickstein: Brigham and Women’s Hospital) followed by two washes with GVB++. Serum from C1qa / (Botto et al., 1998) or MBL-A/C / mice was diluted with GVB++ as indicated and added to round bottom 96-well plates followed by the addition of 3…”
MethodGraudal, N. A., MADSEN, H. O., Tarp, U., Svejgaard, A., Jurik, A. G., Graudal, H. K., & Garred, P. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<515::aid-anr6>3.0.co;2-t · Cited by 116
Genetic insights into disease mechanisms of autoimmunity
Simmonds, M. J., & Gough, S. C. L. (2005) · British Medical Bulletin · doi:10.1093/bmb/ldh032 · Cited by 120
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus
Tsao, B. P., Cantor, R. M., Grossman, J. M., Shen, N., Teophilov, N. T., Wallace, D. J., Arnett, F. C., Hartung, K., Goldstein, R., Kalunian, K. C., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5967 · Cited by 111
Erythrocyte-derived ectosomes have immunosuppressive properties
Sadallah, S., Eken, C., & Schifferli, J. A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108013 · Cited by 117
“A “light” complement activation occurs on apoptotic cells as well, and C1q appears to be important, not only for the uptake of apoptotic cells but also for the prevention of autoimmunity [48].”
BackgroundClarke, E. V., Weist, B. M., Walsh, C. M., & Tenner, A. J. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0614-278r · Cited by 102
“In mice, complete genetic C1q deficiency (or reduced Mf C1q production) results in autoantibody production and murine lupus nephritis on certain strain backgrounds [2–4], consistent with the function of this protein as a regulator of inflammation and autoimmunity.”
BackgroundComplement in Lupus Nephritis: New Perspectives
Bao, L., Cunningham, P. N., & Quigg, R. J. (2015) · Kidney Diseases · doi:10.1159/000431278 · Cited by 116
Serum Amyloid P Aids Complement-Mediated Immunity to Streptococcus pneumoniae
Yuste, J., Botto, M., Bottoms, S. E., & Brown, J. S. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030120 · Cited by 105
“C1qa / mice created by interbreeding the previously described Apcs / and C1qa / mouse strains [5,55].”
MethodSelf-citationMembrane receptors for soluble defense collagens
Tenner, A. J. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80007-7 · Cited by 109
Hedrich, C. M., Smith, E. M. D., & Beresford, M. W. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.02.001 · Cited by 119
Chen, J., Chang, Y., Yao, C., Chiueh, T., Huang, S., Chien, K.-Y., Chen, A., Chang, F., Wong, C., & Chen, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407992101 · Cited by 108
TLR9 and the Recognition of Self and Non‐Self Nucleic Acids
LAMPHIER, M. S., SIROIS, C. M., VERMA, A., GOLENBOCK, D. T., & LATZ, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.005 · Cited by 106
Howell, G. R., MacNicoll, K. H., Braine, C. E., Soto, I., Macalinao, D. G., Sousa, G. L., & John, S. W. M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.016 · Cited by 105
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
Chevilley, A., Lesept, F., Lenoir, S., Ali, C., Parcq, J., & Vivien, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00415 · Cited by 114
Sebastian, B. M., Roychowdhury, S., Tang, H., Hillian, A. D., Feldstein, A. E., Stahl, G. L., Takahashi, K., & Nagy, L. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254201 · Cited by 107
Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance
Harbers, S. O., Crocker, A., Catalano, G., D’Agati, V. D., Jung, S., Desai, D. D., & Clynes, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29470 · Cited by 110
The Pathogenesis of Glaucoma in the Interplay with the Immune System
Rieck, J. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9781 · Cited by 105
Ren, Y., Stuart, L., Lindberg, F. P., Rosenkranz, A. R., Chen, Y., Mayadas, T. N., & Savill, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4743 · Cited by 105
“However, our findings must be set against 1) growing evidence that the first component of complement, C1q, could bridge apoptotic cells to phagocytes in a manner similar to that proposed for TSP1 (41, 42), and 2) compelling data suggesting that Mf receptors for opsonic complement fragments could be important in amplif…”
ResultInfluentialBao, L., Haas, M., Boackle, S. A., Kraus, D. M., Cunningham, P. N., Park, P., Alexander, J. J., Anderson, R. K., Culhane, K., Holers, V. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3601 · Cited by 106
“This also appears to be the case in mice with C1q deficiency (11).”
BackgroundGullstrand, B., Mårtensson, U., Sturfelt, G., Bengtsson, A. A., & Truedsson, L. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03896.x · Cited by 105
Yamaguchi, H., Maruyama, T., Urade, Y., & Nagata, S. (2014) · eLife · doi:10.7554/elife.02172 · Cited by 101
“Inefficient clearance of apoptotic cells causes systemic lupus erythematosus (SLE)-type autoimmune disease in humans and mice (Botto et al., 1998; Hanayama et al., 2004; Munoz et al., 2010).”
BackgroundUnique Protein Signature of Circulating Microparticles in Systemic Lupus Erythematosus
Østergaard, O., Nielsen, C. T., Iversen, L. V., Tanassi, J. T., Knudsen, S., Jacobsen, S., & Heegaard, N. H. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38065 · Cited by 110
C1q: the perfect complement for a synaptic feast?
Perry, V. H., & O'Connor, V. M. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2394 · Cited by 112
“In peripheral tissues the complement cascade has been shown to have a role in tagging apoptotic cells for removal by macrophage”
BackgroundYuste, J., Botto, M., Paton, J. C., Holden, D. W., & Brown, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1813 · Cited by 129
Self-citationPothlichet, J., Niewold, T. B., Vitour, D., Solhonne, B., Crow, M. K., & Si‐Tahar, M. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000120 · Cited by 105
“Many common genetic variations www.embomolmed.org EMBO Mol Med 3, 142–152 have been linked to SLE susceptibility in recent studies (Botto et al, 1998; Hinds et al, 2005).”
BackgroundSelf-dsDNA in the pathogenesis of systemic lupus erythematosus
Bai, Y., Tong, Y., Liu, Y., & Hu, H. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13041 · Cited by 113
C1q Knock-Out Mice for the Study of Complement Deficiency in Autoimmune Disease
Botto, M. (1998) · Experimental and Clinical Immunogenetics · doi:10.1159/000019076 · Cited by 100
Self-citationDevelopment of Autoimmunity in IL-14α-Transgenic Mice
Shen, L., Zhang, C., Wang, T., Brooks, S. R., Ford, R. J., Lin-Lee, Y.-C., Kasianowicz, A., Kumar, V., Martin, L., Liang, P., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5676 · Cited by 110
“Animal models have established that alterations of individual genes that regulate lymphocyte proliferation (8, 9), inhibit apoptosis (10, 11), regulate signaling through the BCR (12–14), determine degradation or clearance of autoantigens (15, 80) or clearance of immune complexes (6, 7) can result in serum autoantibodi…”
BackgroundFadeel, B. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3145-1 · Cited by 114
Pisalyaput, K., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05012.x · Cited by 103
“Other known functions include enhancement of phagocytosis of apoptotic cells and of suboptimally opsonized targets (Bobak et al. 1988; Botto et al. 1998; Vandivier et al. 2002), modulation of cytokine and chemokine production (Fraser et al.”
BackgroundCocca, B. A., Seal, S. N., D’Agnillo, P., Mueller, Y. M., Katsikis, P. D., Rauch, J., WEIGERT, M. G., & Radic, M. Z. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241510698 · Cited by 109
Abrogation of Lupus Nephritis in Activation-Induced Deaminase-Deficient MRL/lpr Mice
Jiang, C., Foley, J., Clayton, N. P., Kissling, G. E., Jokinen, M. P., Herbert, R., & Diaz, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7422 · Cited by 102
“Implicated are defects in B and T cell tolerance, complement activation, cytokine regulation, endothelial cell function, and apoptotic clearance [6–21].”
BackgroundThe role of IgM antibodies in the recognition and clearance of apoptotic cells
Peng, Y., Kowalewski, R., Kim, S., & Elkon, K. B. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.045 · Cited by 111
Modulating apoptosis as a target for effective therapy
Fleischer, A., Ghadiri, A., Dessauge, F., Duhamel, M., Rebollo, M. P., Alvarez-Franco, F., & Rebollo, A. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.013 · Cited by 109
Lynch, N. J., Willis, C. L., Nolan, C. C., Roscher, S., Fowler, M. J., Weihe, E., Ray, D. E., & Schwaeble, W. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.08.009 · Cited by 102
Crosstalk between Complement and Toll-Like Receptors
Song, W. (2011) · Toxicologic Pathology · doi:10.1177/0192623311428478 · Cited by 105
“Furthermore, mice deficient in C1q and C4 also developed autoimmune diseases resembling human SLE with characteristic findings such as glomerulonephritis and appearance of high titer autoantibodies (Botto et al. 1998; Chen, Koralov, and Kelsoe 2000; Paul et al. 2002).”
BackgroundTen, V. S., Yao, J., Ratner, V. I., Sosunov, S. A., Fraser, D. A., Botto, M., Sivasankar, B., Morgan, B. P., Silverstein, S. C., Stark, R. I., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5249-09.2010 · Cited by 102
“C1q knock-out (C1q / ), C6-deficient (C6 / ) mice backcrossed into C57BL/6 strain for 10 and 5 generations (Botto et al., 1998; Morgan et al., 2006) and wild-type (WT) mice (C57BL/6J purchased from The Jackson Laboratory) were bred in the animal facility of Columbia University.”
MethodSelf-citationC-reactive protein and lung diseases
Agassandian, M., Shurin, G. V., Ma, Y., & Shurin, M. R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.016 · Cited by 108
Review: Cell Death, Nucleic Acids, and Immunity
Elkon, K. B. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40452 · Cited by 108
“Both in vitro and in vivo experiments strongly support the idea that the early complement components are required for the clearance of apoptotic cells (12,13).”
BackgroundCutler, A. J., Botto, M., van Essen, D., Rivi, R., Davies, K. A., Gray, D., & Walport, M. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1789 · Cited by 97
“We report here studies on the role of the classical pathway of complement on the induction of antibody production and class switching in response to TD antigen in C1q-deficient mice (29).”
BackgroundMethodSelf-citationClinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
Ludwig, R. J. (2013) · ISRN Dermatology · doi:10.1155/2013/812029 · Cited by 106
“Mice deficient for C1q, in which classical complement activation does not take place [168], showed a small and partial but significant protection from EBA induction.”
BackgroundMafB is a critical regulator of complement component C1q
Tran, M. T., Hamada, M., Jeon, H., Shiraishi, R., Asano, K., Hattori, M., Nakamura, M., Imamura, Y., Tsunakawa, Y., Fujii, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01711-0 · Cited by 103
Sjöwall, C., Bengtsson, A. A., Sturfelt, G. K., & Skogh, T. (2003) · Arthritis Research & Therapy · doi:10.1186/ar1032 · Cited by 106
“Recently, the roles of pentraxins, dysregulated apoptosis and deficient clearance of apoptotic material in SLE have attracted much attention [3–10].”
BackgroundMonteith, A. J., Kang, S., Scott, E., Hillman, K., Rajfur, Z., Jacobson, K., Costello, M. J., & Vilen, B. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513943113 · Cited by 102
“Similarly, impaired clearance of apoptotic bodies in mice lacking scavenger receptors and complement proteins induces spontaneous autoimmunity (7, 8).”
BackgroundCD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine
Devitt, A., Pierce, S., Oldreive, C., Shingler, W. H., & Gregory, C. D. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401168 · Cited by 108
Shoshan, Y., Shapira, I., Toubi, E., Frolkis, I., Yaron, M., & Mevorach, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5963 · Cited by 112
“The interaction index of healthy individuals that had been 541 74 in the presence of human serum, decreased dramatically both by heat inactivation and by C1q, C2, C3, and C4 depletion.”
BackgroundThe contribution of macrophages to systemic lupus erythematosus
Ma, C., Xia, Y., Yang, Q., & Zhao, Y. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.06.009 · Cited by 101
Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis
Fond, A. M., & Ravichandran, K. S. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-39406-0_2 · Cited by 98
“Deficiency of the apoptotic cell bridging molecules C1q or MFG-E8 both result in marked autoimmunity as measured by autoantibodies and the development of glomerulonephritis(Hanayama et al., 2004, Botto et al., 1998).”
BackgroundEfferocytosis and autoimmune disease
Kawano, M., & Nagata, S. (2018) · International Immunology · doi:10.1093/intimm/dxy055 · Cited by 99
Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody
Gulati, S., Beurskens, F. J. M., de Kreuk, B.-J., Roza, M., Zheng, B., DeOliveira, R. B., Shaughnessy, J., Nowak, N., Taylor, R. P., Botto, M., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000323 · Cited by 102
Self-citationMihai, S., Chiriac, M. T., Takahashi, K., Thurman, J. M., Holers, V. M., Zillikens, D., Botto, M., & Sitaru, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6514 · Cited by 97
Self-citationMiwa, T., Maldonado, M. A., Zhou, L., Sun, X., Luo, H., Cai, D., Werth, V. P., Madaio, M. P., Eisenberg, R. A., & Song, W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64268-x · Cited by 106
Complement and human T cell metabolism: Location, location, location
West, E. E., Kunz, N., & Kemper, C. (2020) · Immunological Reviews · doi:10.1111/imr.12852 · Cited by 99
Reynolds, J., Norgan, V. A., Bhambra, U., Smith, J., Cook, H. T., & Pusey, C. D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132359 · Cited by 96
Self-citationInflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism
Cain, D. W., Snowden, P. B., Sempowski, G. D., & Kelsoe, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019957 · Cited by 95
“C1q2/2 mice [27] were obtained from Dr. M. Walport (Imperial College).”
BackgroundTerminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
Carpanini, S. M., Torvell, M., Bevan, R. J., Byrne, R. A. J., Daskoulidou, N., Saito, T., Saido, T. C., Taylor, P. R., Hughes, T. R., Zelek, W. M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01404-w · Cited by 95
Systemic lupus erythematosus biomarkers: the challenging quest
Arriens, C., Wren, J. D., Munroe, M. E., & Mohan, C. (2016) · Rheumatology · doi:10.1093/rheumatology/kew407 · Cited by 102
Kruse, K., Janko, C., Urbonaviciute, V., Mierke, C. T., Winkler, T., Voll, R. E., Schett, G. A., Munoz, L. E., & i, M. H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0478-8 · Cited by 106
Fonseca, M. I., Chu, S.-H., Berci, A. M., Benoit, M. E., Peters, D. G., Kimura, Y., & Tenner, A. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-4 · Cited by 79
“The 3xTg and 3xTgBUB were crossed to C1q knockout mice (C1qa-/-) [23] previously backcrossed onto C57BL/6 or onto the BUB background until homozygous for all markers (validated by PCR and/or QPCR and test breeding) generating 3xTgQ-/- and 3xTgQ-/-BUB respectively.”
Specific Inhibition of the Classical Complement Pathway by C1q-Binding Peptides
Roos, A., Nauta, A. J., Broers, D., Faber‐Krol, M. C., Trouw, L. A., Drijfhout, J. W., & Daha, M. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7052 · Cited by 95
“In addition, recent experiments in C1q knockout mice suggest that at least part of the glomerular complement deposition that accompanies the renal disease in these animals is induced via the alternative pathway (32).”
BackgroundThe immunobiology of TSE diseases
Mabbott, N. A., & Bruce, M. E. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-10-2307 · Cited by 95
“Although very low levels of infectivity have been detected in the blood-stream in some TSE models (reviewed in Brown, 1996), there is no evidence of haematogenous spread of infection from peripheral tissues to the CNS. Neuroinvasion is crucially dependent on PrP expression in a non-haemopoietic…”
Inefficient Clearance of Dying Cells and Autoreactivity
Gaipl, U. S., Sheriff, A., Franz, S., Munoz, L. E., Voll, R. E., Kalden, J. R., & i, M. H. (2006) · Springer eBooks · doi:10.1007/3-540-29714-6_8 · Cited by 103
“In C1q-deficient mice, significantly greater numbers of glomerular apoptotic bodies were found and spontaneous development of autoantibodies was observed [ 9 , 10].”
BackgroundLofano, G., Gorman, M. J., Yousif, A. S., Yu, W., Fox, J. M., Dugast, A., Ackerman, M. E., Suscovich, T. J., Weiner, J. A., Barouch, D. H., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat7796 · Cited by 101
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.